Dose-Adjusted EPOCH-Rituximab Combined With Fludarabine Provides an Effective Bridge to Reduced-Intensity Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Lymphoid Malignancies

PURPOSE: There is currently no standard chemotherapy regimen for patients with lymphoid malignancies being considered for reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation (RIC-alloHSCT). The ideal regimen would provide disease control and result in lymphocyte depleti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Salit, Rachel B., Fowler, Daniel H., Wilson, Wyndham H., Dean, Robert M., Pavletic, Steven Z., Dunleavy, Kieron, Hakim, Frances, Fry, Terry J., Steinberg, Seth M., Hughes, Thomas E., Odom, Jeanne, Bryant, Kelly, Gress, Ronald E., Bishop, Michael R.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2012
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3295571/
https://ncbi.nlm.nih.gov/pubmed/22312100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.37.0296
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados